Sun Pharma shares in focus as co announces plan to acquire Checkpoint Therapeutics for $355 million
Sun Pharmaceutical announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, an immunotherapy and oncology company.
Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million; Details
Sun Pharmaceuticals announced that it will acquire Checkpoint Therapeutics, a company specializing in immunotherapy and ...
Sun Pharma to acquire Nasdaq-listed oncology firm Checkpoint Therapeutics for $335 million
Sun Pharma to acquire Checkpoint Therapeutics, expanding innovative portfolio in onco-derm therapy with FDA-approved UNLOXCYT ...
Fortune India28m
Sun Pharma to acquire Checkpoint Therapeutics for $355 million
The upfront cash payment of $4.10 per share of common stock represents a premium of around 66% to Checkpoint’s closing share ...
Le Lézard13m
MWC2025 | Learning Ability Is Productivity, Empower Talent for an Intelligent Future
During the Mobile World Congress 2025, Huawei successfully held the Digital Intelligence Talent Development Forum, attracting ...
Le Lézard59m
Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its ...